BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 23954667)

  • 21. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions.
    Ichinoe M; Mikami T; Yoshida T; Igawa I; Tsuruta T; Nakada N; Anzai N; Suzuki Y; Endou H; Okayasu I
    Pathol Int; 2011 May; 61(5):281-9. PubMed ID: 21501294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet-derived growth factor stimulates LAT1 gene expression in vascular smooth muscle: role in cell growth.
    Liu XM; Reyna SV; Ensenat D; Peyton KJ; Wang H; Schafer AI; Durante W
    FASEB J; 2004 Apr; 18(6):768-70. PubMed ID: 14977877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional characterization and molecular expression of large neutral amino acid transporter (LAT1) in human prostate cancer cells.
    Patel M; Dalvi P; Gokulgandhi M; Kesh S; Kohli T; Pal D; Mitra AK
    Int J Pharm; 2013 Feb; 443(1-2):245-53. PubMed ID: 23270998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression profiles in T24 human bladder carcinoma cells by inhibiting an L-type amino acid transporter, LAT1.
    Baniasadi S; Chairoungdua A; Iribe Y; Kanai Y; Endou H; Aisaki K; Igarashi K; Kanno J
    Arch Pharm Res; 2007 Apr; 30(4):444-52. PubMed ID: 17489360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The RNA interference of amino acid transporter LAT1 inhibits the growth of KB human oral cancer cells.
    Kim CH; Park KJ; Park JR; Kanai Y; Endou H; Park JC; Kim DK
    Anticancer Res; 2006; 26(4B):2943-8. PubMed ID: 16886618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting glutamine transport to suppress melanoma cell growth.
    Wang Q; Beaumont KA; Otte NJ; Font J; Bailey CG; van Geldermalsen M; Sharp DM; Tiffen JC; Ryan RM; Jormakka M; Haass NK; Rasko JE; Holst J
    Int J Cancer; 2014 Sep; 135(5):1060-71. PubMed ID: 24531984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Tanaka S; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Cancer Sci; 2008 Dec; 99(12):2380-6. PubMed ID: 19018776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogenicity of L-type amino-acid transporter 1 (LAT1) revealed by targeted gene disruption in chicken DT40 cells: LAT1 is a promising molecular target for human cancer therapy.
    Ohkawa M; Ohno Y; Masuko K; Takeuchi A; Suda K; Kubo A; Kawahara R; Okazaki S; Tanaka T; Saya H; Seki M; Enomoto T; Yagi H; Hashimoto Y; Masuko T
    Biochem Biophys Res Commun; 2011 Mar; 406(4):649-55. PubMed ID: 21371427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of LAT1 and LAT2 in the high- and low-affinity transport of L-leucine in human retinal pigment epithelial cells (ARPE-19 cells).
    Yamamoto A; Akanuma S; Tachikawa M; Hosoya K
    J Pharm Sci; 2010 May; 99(5):2475-82. PubMed ID: 19890975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. L-type amino acid transporter 1-mediated L-leucine transport at the inner blood-retinal barrier.
    Tomi M; Mori M; Tachikawa M; Katayama K; Terasaki T; Hosoya K
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2522-30. PubMed ID: 15980244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LAT1 expression in non-small-cell lung carcinomas: analyses by semiquantitative reverse transcription-PCR (237 cases) and immunohistochemistry (295 cases).
    Takeuchi K; Ogata S; Nakanishi K; Ozeki Y; Hiroi S; Tominaga S; Aida S; Matsuo H; Sakata T; Kawai T
    Lung Cancer; 2010 Apr; 68(1):58-65. PubMed ID: 19559497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High- and low-affinity transport of L-leucine and L-DOPA by the hetero amino acid exchangers LAT1 and LAT2 in LLC-PK1 renal cells.
    Soares-da-Silva P; SerrĂ£o MP
    Am J Physiol Renal Physiol; 2004 Aug; 287(2):F252-61. PubMed ID: 15271688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production and characterization of highly tumor-specific rat monoclonal antibodies recognizing the extracellular domain of human L-type amino-acid transporter 1.
    Ohno Y; Suda K; Masuko K; Yagi H; Hashimoto Y; Masuko T
    Cancer Sci; 2008 May; 99(5):1000-7. PubMed ID: 18294274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of L-type amino acid transporter in canine hepatocellular carcinoma.
    Ogihara K; Naya Y; Sato R; Onda K; Ochiai H
    J Vet Med Sci; 2015 May; 77(5):527-34. PubMed ID: 25649314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L-type amino acid transporter-1 expressed in human astrocytomas, U343MGa.
    Asano S; Kameyama M; Oura A; Morisato A; Sakai H; Tabuchi Y; Chairoungdua A; Endou H; Kanai Y
    Biol Pharm Bull; 2007 Mar; 30(3):415-22. PubMed ID: 17329830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.
    Marshall AD; van Geldermalsen M; Otte NJ; Anderson LA; Lum T; Vellozzi MA; Zhang BK; Thoeng A; Wang Q; Rasko JE; Holst J
    Int J Cancer; 2016 Dec; 139(11):2529-39. PubMed ID: 27486861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of L-type amino acid transporter 1 in a rat model of liver metastasis: positive correlation with tumor size.
    Tamai S; Masuda H; Ishii Y; Suzuki S; Kanai Y; Endou H
    Cancer Detect Prev; 2001; 25(5):439-45. PubMed ID: 11718450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-type amino acid transporter 1, LAT1, in growth hormone-producing pituitary tumor cells.
    Satou M; Wang J; Nakano-Tateno T; Teramachi M; Suzuki T; Hayashi K; Lamothe S; Hao Y; Kurata H; Sugimoto H; Chik C; Tateno T
    Mol Cell Endocrinol; 2020 Sep; 515():110868. PubMed ID: 32579901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationship of a novel series of inhibitors for cancer type transporter L-type amino acid transporter 1 (LAT1).
    Kongpracha P; Nagamori S; Wiriyasermkul P; Tanaka Y; Kaneda K; Okuda S; Ohgaki R; Kanai Y
    J Pharmacol Sci; 2017 Feb; 133(2):96-102. PubMed ID: 28242177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.